abstract |
The present invention provides a pharmaceutical composition for transdermal delivery containing at least one physiologically active agent and at least one propellant or at least one volatile pharmaceutically acceptable solvent or a mixture thereof, the physiologically active agent forming a metastable deposition on the skin of the subject upon evaporation of the volatile solvent . |